Cargando…

Validation of death prediction after breast cancer relapses using joint models

BACKGROUND: Cancer relapses may be useful to predict the risk of death. To take into account relapse information, the Landmark approach is popular. As an alternative, we propose the joint frailty model for a recurrent event and a terminal event to derive dynamic predictions of the risk of death. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mauguen, Audrey, Rachet, Bernard, Mathoulin-Pélissier, Simone, Lawrence, Gill M, Siesling, Sabine, MacGrogan, Gaëtan, Laurent, Alexandre, Rondeau, Virginie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404268/ https://www.ncbi.nlm.nih.gov/pubmed/25888480 http://dx.doi.org/10.1186/s12874-015-0018-x

Ejemplares similares

Separate and combined analysis of successive dependent outcomes after breast-conservation surgery: recurrence, metastases, second cancer and death
por: Rondeau, Virginie, et al.
Publicado: (2010)

Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands
por: van Maaren, Marissa C., et al.
Publicado: (2022)

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
por: Bellera, Carine A, et al.
Publicado: (2010)

Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients
por: de Mascarel, I, et al.
Publicado: (2002)

Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up
por: de Mascarel, Isabelle, et al.
Publicado: (2007)

Impact of the COVID-19 lockdown in France on the diagnosis and staging of breast cancers in a tertiary cancer centre
por: Linck, Pierre-Antoine, et al.
Publicado: (2021)

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study
por: Tunon-de-Lara, Christine, et al.
Publicado: (2015)

Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials
por: Lerebours, Florence, et al.
Publicado: (2020)

DNA topoisomerase IIα expression and the response toprimary chemotherapy in breast cancer
por: MacGrogan, G, et al.
Publicado: (2003)

Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
por: Dromer, Françoise, et al.
Publicado: (2007)

Humanization of the mouse mammary gland by replacement of the luminal layer with genetically-engineered preneoplastic human cells
por: Verbeke, Stephanie, et al.
Publicado: (2014)

Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells
por: Verbeke, Stephanie, et al.
Publicado: (2015)

Satisfaction with care among patients with non-metastatic breast cancer: development and first steps of validation of the REPERES-60 questionnaire
por: Defossez, Gautier, et al.
Publicado: (2007)

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)
por: Grellety, Thomas, et al.
Publicado: (2016)

Terahertz refractive index-based morphological dilation for breast carcinoma delineation
por: Cassar, Quentin, et al.
Publicado: (2021)

Survival analysis with correlated endpoints: joint frailty-copula models
por: Emura, Takeshi, et al.
Publicado: (2019)

Breast cancer care compared with clinical Guidelines: an observational study in France
por: Lebeau, Marie, et al.
Publicado: (2011)

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
por: Forlenza, Christopher J., et al.
Publicado: (2021)

MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors
por: Pérot, Gaëlle, et al.
Publicado: (2012)

Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria
por: de Mascarel, Isabelle, et al.
Publicado: (2015)

Using surveillance data to understand cancer trends: an overview in Morocco
por: Obtel, M., et al.
Publicado: (2015)

Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations
por: Rouault, Audrey, et al.
Publicado: (2012)

Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort
por: Lafourcade, Alexandre, et al.
Publicado: (2018)

Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
por: Belaroussi, Yaniss, et al.
Publicado: (2020)

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML
por: Ramaswamy, Kavitha, et al.
Publicado: (2022)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Direct modeling of the crude probability of cancer death and the number of life years lost due to cancer without the need of cause of death: a pseudo-observation approach in the relative survival setting
por: Kipourou, Dimitra-Kleio, et al.
Publicado: (2020)

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.
por: MacGrogan, G., et al.
Publicado: (1996)

Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial
por: Evrard, Serge, et al.
Publicado: (2019)

Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997–2006
por: Woods, Laura M., et al.
Publicado: (2016)

Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers
por: Puccetti, Paolo, et al.
Publicado: (2015)

Suivi de la réponse sérologique au virus SARS-CoV-2 chez des professionnels de santé d'un centre de lutte contre le cancer dans un contexte de pandémie de COVID19 (PRO-SERO-COV)
por: Cantarel, C., et al.
Publicado: (2022)

Evidence against the proposition that “UK cancer survival statistics are misleading”: simulation study with National Cancer Registry data
por: Woods, Laura M, et al.
Publicado: (2011)

Are international differences in breast cancer survival between Australia and the UK present amongst both screen‐detected women and non‐screen‐detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997–2006
por: Woods, Laura M., et al.
Publicado: (2016)

Application of the Joint Frailty Copula Model for Analyzing Time to Relapse and Time to Death of Women with Cervical Cancer
por: Shewa Gari, Firomsa, et al.
Publicado: (2023)

Accuracy of cause of death data routinely recorded in a population-based cancer registry: impact on cause-specific survival and validation using the Geneva cancer registry
por: Schaffar, Robin, et al.
Publicado: (2013)

Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development
por: Grego-Bessa, Joaquim, et al.
Publicado: (2023)

What might explain deprivation-specific differences in the excess hazard of breast cancer death amongst screen-detected women? Analysis of patients diagnosed in the West Midlands region of England from 1989 to 2011
por: Morris, Melanie, et al.
Publicado: (2016)

Factors influencing general practitioners in the referral of elderly cancer patients
por: Delva, Fleur, et al.
Publicado: (2011)

Quality indicators for colorectal cancer surgery and care according to patient-, tumor-, and hospital-related factors
por: Mathoulin-Pélissier, Simone, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5qp36ptovuldsk4tneict84j58